Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-05-14 @ 8:45 PM
Study NCT ID:
NCT03069534
Status:
UNKNOWN
Last Update Posted:
2017-03-03
First Post:
2017-02-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: